Amyris, Inc.

59 articles with Amyris, Inc.

• 

  BioSpace Movers and Shakers: Feb. 15

  2/15/2019

  Pharma and biotech companies strengthen their leadership teams with new hires and appointments at Cadent, bluebird, Abeona, Sanofi, and more.

• Amyris and ADL Bionatur Solutions Expand Production Agreement  to Meet Growing Demand

  12/10/2018

  Amyris, Inc. today announced that it has executed an expanded agreement for its existing production contract with ADL Bionatur Solutions (MAB:ADL), through its fermentation division ADL Biopharma.

• Amyris Enters into Extensive Collaboration Agreement with Leading Chinese Pharmaceutical Company, Yifan Pharmaceutical Co., Ltd.

  9/27/2018

  Amyris, Inc. today announced that it has entered into a multi-year, multi-million-dollar agreement with a subsidiary of Yifan Pharmaceutical Co., Ltd.

• 

  Amyris Joins List of 2018 Best Places to Work in the Bay Area

  4/27/2018

  The San Francisco Business Times and the Silicon Valley Business Journal pulled together to create a list of the Best Places to Work in the Bay Area. Hitting the list at number 23 for large companies is biotechnology company Amyris.

• Amyris, Inc. Enters Into First Product Development And Production Agreement With Royal DSM For Food And Nutrition Molecule

  7/17/2017

• Gen9 And Amyris, Inc. Announce Supply Agreement For Synthetic DNA

  6/2/2016

• Amyris, Inc. Creates Program To Reduce The Cost And Increase Access To Leading Malaria Treatment

  4/12/2016

• Amyris, Inc. Announces Offering Of $50 Million Of Convertible Senior Notes Due 2019

  10/14/2015

• Amyris, Inc. Achieves Record Low Cost Farnesene Production

  10/12/2015

• Amyris, Inc. Announces Multi-Year Technology Investment Agreement With Defense Advanced Research Projects Agency Worth Up To $35 Million

  9/23/2015

• Amyris, Inc. To Enter Into Exclusive Cosmetic Distribution Partnership With Leading Brazil Cosmetic Retailer

  9/11/2015

• Amyris, Inc. And Infectious Disease Research Institute (IDRI) Announce Agreement To Explore Testing And Development Of Amyris Materials For Use In Vaccine Adjuvant Formulations

  9/9/2015

• Amyris, Inc. To Present At Rodman & Renshaw 17th Annual Global Investment Conference On September 9, 2015

  9/3/2015

• Amyris, Inc. Set To Increase Global Growth Of Its Cosmetic Emollients Through ISO 22716 Certification

  9/2/2015

• Amyris, Inc. Achieves Breakthrough Performance With 2nd Fragrance Molecule Ready For Industrial Scale Fermentation In Less Than 12 Months

  8/31/2015

• Amyris, Inc. & Genome Compiler Launch Testing Program For Pharma And Biotech Companies To Explore DNA Design And Construction Solutions

  8/10/2015

• Amyris, Inc. Signing Of Agreements For Conversion And Restructuring Of Approximately $175 Million Of Convertible Debt And $25 Million Private Placement

  7/27/2015

• Amyris, Inc. And Ipca Laboratories Sign Letter Of Intent For Development And Supply Of Active Pharmaceutical Ingredients

  6/9/2015

• Amyris, Inc. Announces Executive Appointments To Accelerate Growth

  6/8/2015

• Amyris, Inc. Announces Designation Of Bram Klaeijsen, Seasoned Global Business Leader From Cargill Incorporated To Board Of Directors

  6/2/2015